ArticleAntibodies (Basel, Switzerland)2019

Antibody-Drug Conjugates Targeting the Urokinase Receptor (uPAR) as a Possible Treatment of Aggressive Breast Cancer.

Efrat T Harel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.